Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of the BinaxNOW™ COVID-19 IgG Rapid Test Device and the BinaxNOW™ COVID-19 Antibody Self Test Clinical Study Protocol

NCT04959760 is registered in ClinicalTrials.gov with Abbott Rapid Diagnostics Jena GmbH as lead sponsor.

NCT NCT04959760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04959760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of the BinaxNOW™ COVID-19 IgG Rapid Test Device and the BinaxNOW™ COVID-19 Antibody Self Test Clinical Study Protocol
Lead sponsor
Abbott Rapid Diagnostics Jena GmbH
Phase
Not applicable
Overall status
Completed
Start date
June 3, 2021
Completion date
January 20, 2022
Enrollment
263 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 respiratory infection